Products will be listed on PAGB's OTC Directory online, a go-to resource for healthcare professionals

CHICAGO, IL / ACCESSWIRE / July 12, 2022 / Cosmos Holdings, Inc. ("the Company") (Nasdaq:COSM), an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of branded and generic pharmaceuticals, nutraceuticals, OTC medications and medical devices, today announced the Company's subsidiary, Decahedron Ltd., a UK-based pharmaceutical wholesaler, distributor and fulfillment center, has been granted full membership to the PAGB, a consumer healthcare association, that represents the manufacturers of branded OTC medicines, self-care medical devices and food supplements in the UK.

PAGB represents 90% of the top 50 UK consumer healthcare brands. Sky Premium Life products will be listed on PAGB's OTC Directory online, the go-to resource for healthcare professionals seeking advice on supporting patients and for consumers seeking self-care.

Decahedron Ltd. specializes in imports and exports of branded and generic pharmaceutical products within the European Economic Area (EEA) and is a distributor of Sky Premium Life products, a luxury line of vitamins and supplements.

"We are honored to receive a full membership with PAGB and to be amongst the top UK consumer healthcare brands such as Glaxo, Sanofi, Bayer, Johnson & Johnson, Bristol Laboratories and others," commented, Greg Siokas, Chief Executive Officer of Cosmos Holdings. "Joining the PAGB means that healthcare professionals will be able to access our products from the OTC directory and recommend them to clients and patients, where they can direct them to purchase products on our Amazon UK storefront or from our Sky Premium Life ecommerce site. On a monthly basis, the OTC directory pages are viewed more than 50,000 times by healthcare professionals. By having our products on the PAGB platform, we can reach additional pharmacy chains, superstores, small pharmacy groups and healthcare products stores. Having the full PAGB membership also provides consumers greater confidence as they know that our products are regulated by PAGB. In addition, PAGB has advertising partners that can help us create a successful marketing campaign that meets industry standards for OTC medicines and food supplements products."

About Cosmos Holdings, Inc.

Cosmos Holdings Inc. (Nasdaq:COSM) is an international pharmaceutical company, with a proprietary line of nutraceuticals and distributor of branded and generic pharmaceuticals, nutraceuticals, OTC medications and medical devices through an extensive, established EU distribution network. The Company identifies, acquires, develops and commercializes products that improve patients' lives and outcomes. Cosmos has developed a global distribution platform and is currently expanding throughout Europe, Asia and North America. Cosmos Holdings has offices and distribution centers in Thessaloniki, Greece, Athens, Greece and Harlow, UK. More information is available at www.cosmosholdingsinc.com and www.skypremiumlife.com.

Forward-Looking Statements

With the exception of the historical information contained in this news release, the matters described herein, may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements preceded by, followed by, or that otherwise, include the words "believes," "expects," "anticipates," "intends," "projects," "estimates," "plans" and similar expressions or future or conditional verbs such as "will," "should," "would," "may" and "could", are generally forward-looking in nature and not historical facts, although not all forward-looking statements include the foregoing. These statements, involve unknown risks and uncertainties that may individually or materially impact the matters discussed, herein for a variety of reasons that are outside the control of the Company, including, but not limited to, the Company's ability to raise sufficient financing to implement its business plan, the impact of the COVID-19 pandemic and the war in Ukraine, on the Company's business, operations and the economy in general, and the Company's ability to successfully develop and commercialize its proprietary products and technologies. Readers are cautioned not to place undue reliance on these forward- looking statements, as actual results could differ materially from those described in the forward-looking statements contained herein. Readers are urged to read the risk factors set forth in the Company's filings with the SEC, which are available at the SEC's website (www.sec.gov). The Company disclaims any intention or obligation to update, or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Investor Relations Contact:
Crescendo Communications, LLC
Tel: 212-671-1020
Email: COSM@crescendo-ir.com

SOURCE: Cosmos Holdings, Inc.